INVESTIGATING THE EFFECT OF THERAPEUTICS ON THE MICROBIOME OF PATIENTS WITH HIV/AIDS
Here, we investigate the pathways by which maraviroc-treated cohorts experience improved mucosal immunity through changes in host:microbial interactions. We hypothesize that maraviroc therapy-induced improvements in mucosal immunity impacts the microbial mucosal interaction through either a change in the distribution of the microbial communities, their metabolic state, or both. We previously performed a three-arm, randomized clinical…